← Leaderboards
Thomas J Langan
University Of Minnesota
$2,970,891
Attributed
$3,190,203
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $760.6K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,190,203 · 3
By mechanism
R01$2,716,923 · 1
R21$438,625 · 1
U54$34,655 · 1
Top collaborators
- Randolph Lee Carter2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Branden S Moriarity$9,306,595
- Piya S Kishnani$385,959
- Agnes Huang Chen$237,950
- Bruce R. Blazar$144,460,093
- Alvaro Alonso$12,399,860
Others in their field
Top investigators on “Follow-Up”
- Jeffrey P Krischer · University Of South Florida$398,381,597
- James Dennis Neaton · Northwestern University$283,212,546
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S Hochman · New York University School Of Medicine$125,409,158
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$119,981,780
- David R. Weir · University Of Michigan At Ann Arbor$119,885,186
Research focus
Follow-UpNeonatal ScreeningGloboid Cell LeukodystrophyBaseChildMortalityDiagnosticMissouriInfantProspectiveDiagnosisEnzymesPsychosineMorbidity - Disease RateBloodLifeBiological MarkersGalactosylceramidaseNewborn InfantNew YorkHigh RiskIllinoisScreening ResultSource
Grant awards (11)
Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1$622,533
R01 · FY2025 · HD · contact PI
Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1$626,874
R01 · FY2024 · HD · contact PI
Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1$706,872
R01 · FY2023 · HD · contact PI
Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1$760,644
R01 · FY2022 · HD · contact PI
Long Term Follow up for Krabbe Disease$6,931
U54 · FY2018 · NS · contact PI
Enhancement Newborn Screening to Improve the Efficacy of Cord Blood Transplant for Krabbe Disease$199,375
R21 · FY2017 · HD · contact PI
Long Term Follow up for Krabbe Disease$6,931
U54 · FY2017 · NS · contact PI
Enhancement Newborn Screening to Improve the Efficacy of Cord Blood Transplant for Krabbe Disease$239,250
R21 · FY2016 · HD · contact PI
Long Term Follow up for Krabbe Disease$6,931
U54 · FY2016 · NS · contact PI
Long Term Follow up for Krabbe Disease$6,931
U54 · FY2015 · NS · contact PI
Long Term Follow up for Krabbe Disease$6,931
U54 · FY2014 · NS · contact PI